Company intelligence / Profile preview

InnoStudio

Budapest, Budapest, Hungaryinnostudio.org ↗

Ownership: Private
Development stage: Commercial

Overview

InnoStudio has pioneered the use of flow chemistry for both terrestrial and space-based applications. It led the first experiment to study remdesivir-SBECD complex formation under microgravity conditions aboard the ISS to support COVID‑19 drug discovery. The company also develops advanced pesticide formulations that reduce application amounts by 30–70%, supporting sustainable agriculture. There are no reported clinical results for human therapeutics.

Therapeutic areas: OtherInfectious Diseases
Modalities: Small moleculeNanoparticleFormulation technology
Industry: Agriculture & AgTech

Partnerships

AgroThetisJapan Manned Space Systems Corporation/JAMSS ("Kirara" service for space experiments)European Space Agency via ICE Cubes Facility partnership for ISS experiments

Beyond the preview

Go deeper on InnoStudio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on InnoStudio.

Explore the full profile